Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
China NT Pharma Group Co., Ltd. ( (HK:1011) ) has shared an announcement.
China NT Pharma Group Co., Ltd. announced the successful completion of a profit guarantee related to its associate, Beijing Kangchen Biotechnology Company Limited. The profit guarantee, which was part of a larger acquisition agreement with Beijing Konruns Pharmaceutical Company Limited, required the associate’s Miacalcic business to achieve specific net profit targets from 2021 to 2023. The associate exceeded these targets each year, signaling strong performance and potentially enhancing NT Pharma’s industry positioning and stakeholder confidence.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is involved in various aspects of the pharmaceutical supply chain, including research and development, production, and sales, with a market focus on China and international markets.
Average Trading Volume: 1,273,594
Technical Sentiment Signal: Hold
Current Market Cap: HK$252.8M
For detailed information about 1011 stock, go to TipRanks’ Stock Analysis page.